When we tried to correlate genomic features of SCLC tumors to the STING activation levels, we found that STING‐low tumors had higher mutation frequency in NOTCH‐pathway genes compared with STING‐high tumors. The gene discussed is STING1; the disease is small cell lung carcinoma.